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Abstract
Background
Chronic obstructive pulmonary disease (COPD) is a major respiratory disorder, largely
caused by smoking that has been linked with large health inequalities worldwide. There are
important gaps in our knowledge about how COPD affects Aboriginal peoples. This retro-
spective cohort study assessed the epidemiology of COPD in a cohort of Aboriginal peoples
relative to a non-Aboriginal cohort.
Methods
We used linkage of administrative health databases in Alberta (Canada) from April 1, 2002
to March 31, 2010 to compare the annual prevalence, and the incidence rates of COPD be-
tween Aboriginal and non-Aboriginal cohorts aged 35 years and older. Poisson regression
models adjusted the analysis for important sociodemographic factors.
Results
Compared to a non-Aboriginal cohort, prevalence estimates of COPD from 2002 to 2010
were 2.3 to 2.4 times greater among Registered First Nations peoples, followed by the Inuit
(1.86 to 2.10 times higher) and the Métis (1.59 to 1.67 times higher). All Aboriginal peoples
had significantly higher COPD incidence rates than the non-Aboriginal group (incidence
rate ratio [IRR]: 2.1; 95% confidence interval [CI]: 1.97, 2.27). COPD incidence rates were
higher in First Nation peoples (IRR: 2.37; 95% CI: 2.19, 2.56) followed by Inuit (IRR: 1.92;
95% CI: 1.64, 2.25) and Métis (IRR: 1.49; 95% CI: 1.32, 1.69) groups.
Conclusions
We found a high burden of COPD among Aboriginal peoples living in Alberta; a province
with the third largest Aboriginal population in Canada. Altogether, the three Aboriginal
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peoples groups have higher prevalence and incidence of COPD compared to a non-Aborigi-
nal cohort. The condition affects the three Aboriginal groups differently; Registered First Na-
tions and Inuit have the highest burden of COPD. Reasons for these differences should be
further explored within a framework of social determinants of health to help designing inter-
ventions that effectively influence modifiable COPD risk factors in each of the Aboriginal
groups.
Introduction
Chronic obstructive pulmonary disease (COPD) is a respiratory disorder largely caused by
smoking and characterized by progressive, not fully reversible airway obstruction, systemic
manifestations, and increasing frequency and severity of exacerbations [1]. Worldwide esti-
mates of COPD prevalence are in the range of 5% to 10% [2], whereas COPD incidence rates
have shown variations between 2 to 6 cases per 1,000 person-years, depending on the case defi-
nition and the study population [3].
Aboriginal peoples of Canada (First Nations peoples, Métis and Inuit) are particularly af-
fected by respiratory diseases; the epidemiology of their respiratory problems closely mimics
that of populations in many low-and middle-income countries. There are important gaps in
our knowledge about the burden of COPD in Aboriginal peoples relative to their non-Aborigi-
nal counterparts [4]. Analyses of community surveys [5] and administrative health data [6–8]
have suggested that Aboriginal peoples in Canada have higher prevalence and incidence of
COPD compared to non-Aboriginal populations. These studies, however, have used cross-sec-
tional designs with self-reporting of physician diagnoses, spanned relatively short periods of
observation, and limited their scope to specific Aboriginal groups (i.e., Registered First Nations
or Métis only).
This is the first large, longitudinal, cohort study that evaluated the epidemiology of COPD
in all three Aboriginal groups in Canada. Using a retrospective cohort design covering eight
years of administrative health data from Alberta (Canada), we assessed the prevalence and inci-
dence of COPD in the three Aboriginal groups of Registered First Nations peoples, Métis and
Inuit relative to a non-Aboriginal population in the province while controlling for the potential
impact of sociodemographic factors.
Materials and Methods
Study setting and data sources
Alberta is a culturally diverse province located in western Canada with a population of over 4
million residents, of which approximately 6.2% report Aboriginal ancestry [9]. A total of
220,695 Aboriginal people lived in Alberta by 2011, representing 15.8% of the total Aboriginal
population in Canada [9]. Of these, approximately 52% are First Nations peoples, 45% are
Métis and less than 1% are Inuit [9].
We obtained de-identified individual-level, longitudinal data by fiscal year (April 1st of a
given year to March 31st of the subsequent year) from 2002 to 2010 from administrative health
databases in Alberta that included records of all individuals eligible for coverage (~99% of the
total population) under the publicly-funded Alberta Health Care Insurance Plan (AHCIP).
Health premiums of Registered First Nations and Inuit are paid by the Canadian federal
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government, whereas Métis do not have special federal coverage of health services provided in
the province.
Administrative health databases contained demographic information (AHCIP population
registry), data on all acute and elective hospital discharges using the International Classification
of Diseases, 10th Revision; enhanced Canadian version (ICD-10-CA) for diagnosis coding [10]
(Morbidity and Ambulatory Care Reporting System), claims for services provided by fee-for-
service physicians and physicians paid under alternate payment plans with diagnostic fee codes
based on the International Classification of Diseases, 9th Revision (ICD-9) [11] (Alberta Physi-
cian Claims Assessment System), and deaths that occur within the province (Alberta Vital Sta-
tistics). Additionally, the Métis Nation of Alberta (MNA) Identification Registry includes
citizenship information for Métis members.
Individual records were linked across datasets based on an encrypted unique personal
health number. Deterministic data linkage was used across administrative health databases,
whereas probabilistic linkage was used to link data from the MNA registry with the other
datasets.
Ethics Statement
Ethics approval was obtained from the University of Alberta’s Health Research Ethics Board
(HREB), in Edmonton, Alberta (Canada) (MS2_Pro 00010415). Individual patient consent was
not required; however, patient records/information were anonymized and de-identified prior
to analysis.
Study population
The eligibility criteria for this study were individuals with constant registration in the AHCIP
from fiscal years 2002 to 2010, who were at least 35 years of age at the beginning of each year.
For the definition of the study cohorts, Aboriginal peoples were individuals with an alternate
premium arrangement in the AHCIP registry (Registered First Nations, and Inuit) or, individ-
uals identified in the MNA identification registry as Métis. Non-Aboriginals were individuals
in the AHCIP registry without an alternate premium arrangement field, and not included in
the MNA registry. First Nations without registration under the Indian Act [12] and Métis not
included in the MNA registry were considered part of the non-Aboriginal population as there
is no reliable method to identify them within the general population [13].
All Métis and Inuit in the AHCIP/population registry who met the eligibility criteria were
included in the Aboriginal cohort. Random samples of eligible Registered First Nations and
non-Aboriginals were selected from the AHCIP/population registry for a ratio of five Regis-
tered First Nations and five non-Aboriginals per Métis included. Cohort matching by age or
sex was not considered because it was unlikely that it would improve study efficiency.
Identification of COPD cases
We used a validated algorithm to identify COPD cases in our study population from adminis-
trative data (Fig 1): individuals aged 35 years and older at the time of diagnosis who have at
least two physician claims with an ICD-9 code (491, 492, 496) of COPD in the first diagnostic
field in a two-year period, or one recording of an ICD-10-CA code (J41-J44) of COPD in any
diagnostic field in the hospital discharge abstract ever, whichever came first. The two physician
claims must have been on different days. When the case definition was met by two physician
claims, the date of diagnosis was the date of the second physician claim [14]. This COPD algo-
rithm has been previously validated with sensitivity of 68.4%, specificity of 93.5%, positive
COPD among Aboriginal Peoples in Alberta, Canada
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predictive value of 79.2%, and negative predictive value of 89.1% [15]. The index date was the
date of diagnosis of COPD.
Statistical Methods
Annual COPD prevalence for the study cohorts was calculated from fiscal years 2002 to 2010.
For each fiscal year, the numerator was the number of active (alive) COPD cases from the pre-
vious fiscal year plus the new COPD cases detected by the end of the fiscal year. The denomina-
tor was the population at the beginning of the fiscal year minus ½ the total number of deaths
that occurred in that year. Historical information on COPD diagnoses was collected from
April 1, 1994 onwards to allow an eight-year run-in period to identify prior prevalent COPD
cases present at the start of the study period [16]. Prevalence estimates were expressed as
percentages.
Annual COPD incidence rates in the study cohorts were calculated from fiscal years 2002 to
2010. The numerator was the number of new COPD cases per year and the denominator was
the person-time of observation (the sum of time that each person remained under risk and
disease-free until COPD diagnosis, death, or end of fiscal year; whichever came first).
Fig 1. Algorithm for COPD case identification in administrative databases.
doi:10.1371/journal.pone.0123204.g001
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Incidence density rates were calculated as the total number of new COPD cases that oc-
curred between fiscal years 2002 to 2010 divided by total person-time of observation (the sum
of the time that each person remained under risk and free from disease until COPD diagnosis,
death, or end of study; whichever occurred first). All incidence rates were expressed as COPD
cases per 1,000 person-years.
We obtained information from the AHCIP registry on study covariates (e.g., sex, age, area
of residence and socioeconomic status [SES]). Age was grouped into five 10-year intervals
(35–44 years, 45–54 years, 55–64 years, 67–74 years, and 75 years and over). Area of residence
was classified into urban, rural, and remote. Health care premiums in Alberta are full or par-
tially subsidized for individuals qualifying for social assistance. As there is no direct measure of
SES reported in administrative health databases in Canada, the need for, and receipt of health
care subsidies (full, partial, none) is considered a proxy measure of SES within the Canadian
health care system [17].
We adjusted all COPD estimates by age and sex using the direct standardization method
[18] and the 1991 Canadian Census population as reference [19]. Unadjusted prevalence ratios
(PR) per fiscal year were calculated. Poisson regression models were fitted for each fiscal year
to adjust PRs for covariates at baseline (sex, age, area of residence and SES). Unadjusted inci-
dence rate ratios (IRR) were calculated for every fiscal year and for the entire study period.
Poisson regressions adjusted the IRRs by covariates at baseline, using person-time as the offset
in the models. The non-Aboriginal cohort was the reference category in all analyses. All preva-
lence and incidence estimates were reported with 95% confidence intervals (CI), and two-sided
p-values less than 0.05 represented statistical significance. Statistical analyses were performed
using Predictive Analysis Software Statistics for Mac (PASW version 18.0, IBM SPSS, Somers
NY).
Role of funding source
The sponsors of the study had no role in the design, data collection, analysis, data interpreta-
tion, or writing of the manuscript. The corresponding author had full access to all the study
data and had final responsibility for the decision to submit for publication. The opinion, results
and conclusions reported in this paper are those of the authors, and independent from
funding sources.
Results
A total of 79,824 individuals were followed-up over the 8-year study period (Registered First
Nations [n = 32,805], Inuit [n = 1,679] Métis [n = 7,273] and non-Aboriginals [n = 38,067).
(Table 1). Table 2 provides a description of the number of study participants and the number
of COPD prevalent cases per year. Standardized annual COPD prevalence estimates were
higher in the three Aboriginal groups than in the non-Aboriginal group, with Registered First
Nations and the Inuit having the highest COPD prevalence followed by the Métis (Fig 2). Un-
adjusted PRs indicated that compared to the non-Aboriginal group, Aboriginal peoples had
significantly higher annual COPD prevalence in every fiscal year (Table 3), particularly in Reg-
istered First Nations and Inuit groups but not in the Métis.
After adjusting for covariates (Table 3), all annual PRs were significantly higher for all Ab-
original groups compared to the reference group. Compared to the non-Aboriginal group, Reg-
istered First Nations were between 2.3 and 2.4 times more likely to have COPD from 2002 to
2010, followed by the Inuit (1.86 to 2.10 times more likely) and the Métis (1.59 to 1.67 times
more likely).
COPD among Aboriginal Peoples in Alberta, Canada
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A total of 3,885 new cases of COPD were identified over the 8-year study period. Standard-
ized COPD incidence rates showed annual fluctuations over time, particularly among the Inuit
and Métis groups (Fig 3). The standardized COPD incidence density rate for the entire study
period in the Aboriginal peoples cohort combined was 11.3 cases per 1,000 person-years (95%
CI: 11.2, 11.4/1,000 person-years), which doubled that of the non-Aboriginal group (5.5; 95%
CI: 5.4, 5.6/1,000 person-years). Standardized COPD incidence density rates of the three
Table 1. Characteristics of the study cohorts, fiscal years 2002 to 2010.
2002/2003 2003/2004 2004/2005 2005/2006 2006/2007 2007/2008 2008/2009 2009/2010
Total population at baseline 63,274 65,606 67,968 70,503 72,903 75,265 77,548 79,824
Aboriginal groups (%) 48.7 49.3 49.8 50.4 50.9 51.5 51.9 52.3
Registered First Nations (%) 36.9 37.5 38.1 38.8 39.4 40.1 40.6 41.1
Métis (%) 9.4 9.4 9.4 9.3 9.3 9.2 9.2 9.1
Inuit (%) 2.4 2.4 2.3 2.3 2.2 2.2 2.1 2.1
Non-Aboriginal (%) 51.3 50.7 50.2 49.6 49.1 48.5 48.1 47.7
Male (%) 49.2 49.2 49.2 49.2 49.1 49.1 49.1 49.1
Age (yr) (SD) 51.3 (12.7) 51.7 (12.8) 52.1 (13.0) 52.5 (13.2) 52.9 (13.4) 53.3 (13.5) 53.7 (13.7) 54.2 (13.9)
Age groups (%)
35–44 yr 39.2 38.0 36.7 35.4 34.2 32.7 31.4 30.0
45–54 yr 28.3 28.5 28.9 29.3 29.5 29.8 29.9 29.9
55–64 yr 16.4 16.7 17.0 17.2 17.5 18.0 18.5 19.1
65–74 yr 9.9 10.0 10.1 10.4 10.5 10.6 10.8 11.0
 75 yr 6.2 6.8 7.3 7.7 8.3 8.9 9.4 10.0
Area of residence (%)
Urban 60.8 60.6 60.8 60.5 60.7 60.6 60.7 60.6
Rural 30.6 30.7 30.6 30.8 30.6 30.7 30.6 30.6
Remote 8.6 8.6 8.7 8.7 8.7 8.7 8.7 8.8
Subsidy level (%)
Full 15.9 15.5 15.5 23.5 23.9 24.2 23.9 23.7
Partial 1.5 1.5 1.7 0.7 0.2 0.5 0.5 0.5
None 82.6 83.0 82.8 75.8 75.9 75.3 75.6 75.8
COPD = chronic obstructive pulmonary disease; SD = standard deviation; yr = year(s)
doi:10.1371/journal.pone.0123204.t001
Table 2. Study population and number of prevalent cases of COPD per year in Aboriginal and non-Aboriginal cohorts.
Fiscal Year Registered First Nations Métis Inuit Non-Aboriginal
N COPD prevalent cases N COPD prevalent cases N COPD prevalent cases N COPD prevalent cases
2002/2003 23,329 886 5,952 158 1,530 106 32,463 771
2003/2004 24,621 1,063 6,159 192 1,546 123 33,280 915
2004/2005 25,938 1,266 6,358 228 1,567 142 34,105 1,115
2005/2006 27,415 1,455 6,557 271 1,589 170 34,942 1,322
2006/2007 28,782 1,638 6,747 316 1,650 193 35,764 1,469
2007/2008 30,179 1,859 6,927 354 1,643 212 36,516 1,652
2008/2009 31,477 2,090 7,114 390 1,661 230 37,296 1,858
2009/2010 32,805 2,324 7,273 439 1,679 245 38,067 2,064
COPD = chronic obstructive pulmonary disease
doi:10.1371/journal.pone.0123204.t002
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Aboriginal groups were all higher than those of the non-Aboriginal group, with First Nations
having the highest COPD incidence density rates (12.3; 95% CI: 12.1, 12.4/1,000 person-years)
followed by the Inuit (10.1; 95% CI: 9.7, 10.5/1,000 person-years) and the Métis (8.6; 95% CI:
8.3, 8.8/1,000 person-years).
For every fiscal year, Aboriginal peoples, as a whole group, had significantly higher unad-
justed IRR of COPD than the non-Aboriginal group (Table 4). When Aboriginal subgroups
were compared to the non-Aboriginal group, we found that the unadjusted COPD IRRs were
significantly higher for the Inuit and First Nations only. After adjusting for age, sex, SES and
area of residence, all Aboriginal groups had significantly higher COPD IRRs compared to the
non-Aboriginal group for every study year.
The pattern of differences relative to the non-Aboriginal groups on the annual COPD inci-
dence rates over time was not equal for all three Aboriginal groups. Registered First Nations
had between 2 to 2.66 times more incident cases of COPD per 1,000 person-years than the
non-Aboriginal group, and all annual COPD incidence rates were significantly different over
the study period. The Inuit had between 1.42 to 2.22 times more incident cases of COPD per
1,000 person-years than the non-Aboriginal group; however, differences between groups were
not significant for some years (2004 to 2005 and 2008 to 2009). The Métis had between 1.2 to
1.85 times more incident COPD cases per 1,000 person-years than the non-Aboriginal group;
Fig 2. Annual age- and sex-standardized COPD prevalence rates in Aboriginal peoples and the non-Aboriginal population in Alberta, Canada from
fiscal years 2002 to 2010.
doi:10.1371/journal.pone.0123204.g002
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however, differences were not significant for the first two years of the study and for the year
2007.
After the IRR of COPD was adjusted for important sociodemographic factors (Fig 4), we
found that all Aboriginal peoples had a significantly higher number of new COPD cases than
the non-Aboriginal group (IRR 2.1; 95% CI: 1.97, 2.27). Compared to non-Aboriginals, the
number of COPD incident cases was higher among First Nations (IRR 2.37; 95% CI: 2.19, 2.56)
followed by the Inuit (IRR 1.92; 95% CI: 1.64, 2.25) and the Métis (IRR 1.49; 95% CI: 1.32,
1.69).
Discussion
This is the first study to provide a comprehensive longitudinal assessment of the epidemiology
of COPD in the three Aboriginal groups of Canada compared to a non-Aboriginal reference
group. Using a validated algorithm for case identification and adjusting for important sociode-
mographic factors, we found that the three Aboriginal groups had a higher prevalence and inci-
dence of COPD than the non-Aboriginal population. There were differences in the burden of
COPD across the three Aboriginal groups, with Registered First Nations and Inuit having the
highest COPD rates followed by the Métis. These results are broadly in line with other unpub-
lished longitudinal Canadian studies reporting a higher prevalence and incidence of COPD in
specific Aboriginal groups (i.e., Métis) [6–8].
The increased epidemiology of COPD among Aboriginal peoples in our study is likely ex-
plained through multiple mechanisms. First, smoking is the most important etiologic factor in
Table 3. Annual unadjusted and adjusted prevalence ratios (PR) of COPD among Aboriginal groups in Alberta (Canada) from fiscal years 2002 to
2010.
Fiscal year All aboriginal groups First Nations Métis Inuit
COPD PR (95% CI) COPD PR (95% CI) COPD PR (95% CI) COPD PR (95% CI)
Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted
2002–2003 1.57 2.13 1.59 2.31 1.11 1.60 2.91 2.10
(1.43, 1.72)** (1.92, 2.36)** (1.45, 1.76)** (2.06, 2.58)** (0.94, 1.32) (1.34, 1.91)** (2.38, 3.57)** (1.70, 2.59)**
2003–2004 1.48 2.12 1.50 2.30 1.04 1.59 2.85 2.04
(1.36, 1.60)** (1.92, 2.33)** (1.38, 1.64)** (2.08, 2.54)** (0.89, 1.22) (1.35, 1.87)** (2.37, 3.42)** (1.68, 2.48)**
2004–2005 1.44 2.12 1.46 2.32 1.03 1.61 2.70 1.98
(1.34, 1.55)** (1.94, 2.32)** (1.35, 1.58)** (2.11, 2.55)** (0.89, 1.19) (1.39, 1.86)** (2.28, 3.21)** (1.65, 2.38)**
2005–2006 1.39 2.15 1.39 2.40 1.03 1.61 2.76 1.97
(1.29, 1.48)** (1.98, 2.34)** (1.29, 1.50)** (2.19, 2.62)** (0.91, 1.18) (1.41, 1.85)** (2.36, 3.24)** (1.66, 2.34)**
2006–2007 1.36 2.15 1.35 2.37 1.07 1.68 2.76 1.97
(1.28, 1.45)** (1.98, 2.33)** (1.26, 1.45)** (2.17, 2.58)** (0.95, 1.21) (1.48, 1.91)** (2.38, 3.21)** (1.68, 2.32)**
2007–2008 1.34 2.14 1.32 2.37 1.07 1.67 2.72 2.00
(1.26, 1.42)** (1.98, 2.31)** (1.24, 1.41)** (2.18, 2.57)** (0.96, 1.20) (1.48, 1.88)** (2.36, 3.13)** (1.71, 2.33)**
2008–2009 1.33 2.12 1.32 2.37 1.07 1.63 2.69 1.95
(1.26, 1.41)** (1.97, 2.28)** (1.24, 1.40)** (2.18, 2.56)** (0.96, 1.19) (1.45, 1.83 ** (2.35, 3.08)** (1.68, 2.26)**
2009–2010 1.32 2.07 1.30 2.31 1.1 1.61 2.71 1.86
(1.25, 1.40)** (1.93, 2.22)** (1.23, 1.38)** (2.14, 2.49)** (0.99, 1.21) (1.44, 1.80 ** (2.38, 3.08 ** (1.61, 2.16)**
Reference group: Non-Aboriginal population. Adjusted for sex (male, female), age group (35–44 years, 45–54 years, 55–64 years, 65–74 years, 75 years
and over), socioeconomic status proxy (full subsidy, partial subsidy, no subsidy), area of residence (urban rural, remote)
95% CI = 95% conﬁdence interval; COPD = chronic obstructive pulmonary disease; PR = prevalence ratios
** p<0.001
doi:10.1371/journal.pone.0123204.t003
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the development of COPD [20,21]. The administrative data used in this study, while robust,
did not contain smoking history or pack years. Smoking rates in Canada’s Aboriginal popula-
tions are, on average, twice as high as those of non-Aboriginal Canadians (~21%), with higher
rates for the Inuit (~49%), followed by First Nations (~40%) and Métis (~37%) compared to
non-Aboriginals [22]. Therefore, it is reasonable to expect that epidemiological indicators of
COPD would be higher in Aboriginal peoples compared to the non-Aboriginal population.
Similarly, exposure to environmental contaminants derived from biomass fuel burned for
cooking, and living in poorly ventilated areas can also increase the risk of COPD among certain
Aboriginal groups who follow a traditional lifestyle or live on reserves [23]. Interactions be-
tween smoking, housing conditions and crowding, material and social deprivation [24], remote
location of residence [25], low education [26], poor nutrition, and prenatal and childhood ex-
posures to cigarette smoking are likely to be distal and intermediate mechanisms for the higher
epidemiological indicators of COPD burden among Aboriginal peoples in our study.
This study has several limitations. The process of diagnosing COPD is complex and imper-
fect. While the diagnosis of COPD was not clinically confirmed, the algorithm for case identifi-
cation has been shown to be valid and have high accuracy [15]. To conduct a similar sized
Fig 3. Annual age- and sex-standardized COPD incidence rates in Aboriginal peoples and the non-Aboriginal population in Alberta, Canada from
fiscal years 2002 to 2010.
doi:10.1371/journal.pone.0123204.g003
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clinical study would require an enormous funding commitment and many years of research
compared to efficiency of using administrative databases. Superficial clinical details in adminis-
trative databases precluded the acquisition of information on key clinical and sociodemo-
graphic confounding variables (e.g., smoking status, smoking history, body mass index, dietary
intake, exercise, etc.) to adjust the baseline risk for COPD in multivariate analyses.
An important strength of this study was the comprehensive methods to identify individuals
in the Aboriginal cohorts. This is one of the first studies of its kind in Canada that identified
Registered First Nations, Métis and Inuit within an Aboriginal cohort, thus reducing the im-
pact of misclassification bias related to the definition of Aboriginal status. Other studies assess-
ing the health status of Aboriginal peoples in Canada [27–30] have not included Inuit and
Métis populations in their analyses. Limitations encountered in similar studies, however, per-
sisted into a lesser degree as approximately one-third of Aboriginal peoples in the province
Table 4. Adjusted and unadjusted incidence rate ratios (IRR) of COPD among Aboriginal groups in Alberta (Canada) from fiscal years 2002 to
2010.
Fiscal year All aboriginal groups First Nations Métis Inuit
COPD IRR (95% CI) COPD IRR (95% CI) COPD IRR (95% CI) COPD IRR (95% CI)
Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted
2002–2003 1.35 2.11 1.39 2.39 0.82 1.24 2.84 2.22
(1.13, 1.61)
**
(1.73, 2.57)
**
(1.16, 1.68)
**
(1.94, 2.95)
**
(0.57, 1.18) (0.86, 1.80) (1.93, 4.18)
**
(1.49, 3.30)
**
2003–2004 1.30 2.06 1.34 2.27 0.84 1.35 2.57 2.09
(1.09, 1.55)
**
(1.68, 2.52)
**
(1.11, 1.62)
**
(1.83, 2.82)
**
(0.58, 1.21) (0.93, 1.96) (1.70, 3.89)
**
(1.37, 3.19)
**
2004–2005 1.42 2.14 1.50 2.50 1.00 1.44 1.87 1.42
(1.18, 1.71)
**
(1.74, 2.63)
**
(1.23, 1.82)
**
(2.00, 3.12)
**
(0.70, 1.43) (1.00, 2.08)
**
(1.12, 3.12)
**
(0.85, 2.39)
2005–2006 1.29 1.87 1.23 2.03 1.10 1.40 3.09 2.04
(1.07, 1.54)
**
(1.53, 2.29)
**
(1.01, 1.50)
**
(1.62, 2.53)
**
(0.79, 1.53) (1.00, 1.96) (2.08, 4.58)
**
(1.37, 3.06)
**
2006–2007 1.41 2.15 1.34 2.36 1.41 1.85 2.67 1.77
(1.16, 1.71)
**
(1.73, 2.68)
**
(1.09, 1.65)
**
(1.86, 2.99)
**
(1.02, 1.95)
**
(1.32, 2.58)
**
(1.68, 4.2)** (1.11, 2.84)
**
2007–2008 1.36 2.06 1.36 2.43 1.10 1.36 2.47 1.72
(1.14, 1.62)
**
(1.69, 2.05)
**
(1.12, 1.64)
**
(1.96, 3.01)
**
(0.79, 1.53) (0.97, 1.90) (1.59, 3.83)
**
(1.10, 2.68)
**
2008–2009 1.51 2.22 1.56 2.66 1.14 1.43 2.30 1.60
(1.26, 1.81)
**
(1.82, 2.71)
**
(1.29, 1.88)
**
(2.15, 3.30)
**
(0.82, 1.59) (1.01, 2.00)
**
(1.44, 3.69)
**
(0.99, 2.58)
2009–2010 1.45 2.01 1.41 2.25 1.36 1.53 2.70 1.76
(1.21, 1.74)
**
(1.64, 2.45)
**
(1.17, 1.71)
**
(1.81, 2.80)
**
(1.00, 1.86) (1.12, 2.11)
**
(1.74, 4.20)
**
(1.12, 2.11)
**
Incidence density rate
2002–2010
1.48 2.11 1.52 2.37 1.08 1.49 2.54 1.92
(1.39, 1.58)
**
(1.97, 2.27)
**
(1.42, 1.63)
**
(2.19, 2.56)
**
(0.96, 1.22) (1.32, 1.69)
**
(2.18, 2.96)
**
(1.64, 2.25)
**
Reference group: Non-Aboriginal population. Adjusted for sex (male, female), age group (35–44 years, 45–54 years, 55–64 years, 65–74 years, 75 years
and over), socioeconomic status proxy (full subsidy, partial subsidy, none), area of residence (urban rural, remote)
95% CI = 95% conﬁdence interval; COPD = chronic obstructive pulmonary disease; IRR = incidence rate ratios
** p<0.05
doi:10.1371/journal.pone.0123204.t004
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may have been undercounted. For example, an individual classified in the non-Aboriginal
group may have been in fact, a non-Registered First Nations person or a Métis without citizen-
ship registration (approximately 70% of the Métis population in the province). We acknowl-
edge the designation of Aboriginal groups is imperfect, and these numbers likely under-
estimate those Albertans who refer to themselves as Aboriginal.
Finally, the cohort design with linkage of a variety of provincial administrative health data-
bases involved a large number of people with wide coverage and continuity of data over a
Fig 4. Unadjusted and adjusted COPD incidence rate ratios for Aboriginal groups for the entire study period 2002 to 2010.
doi:10.1371/journal.pone.0123204.g004
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relatively long follow-up period. It is within reason to expect that our results can be generalized
to Aboriginal peoples in Alberta and allow inferences that can be applied to Aboriginal popula-
tions in other Canadian provinces.
Future epidemiological research should help to improve our understanding of how Aborigi-
nal status intersects with other social determinants of health to create inequitable conditions
associated with a higher risk of COPD. Distinctions in the origin, form and impact of these de-
terminants and how they affect distinctly Aboriginal peoples groups will have powerful impli-
cations for health services policy and planning. The incorporation of an equity lens within the
existing respiratory health research agenda is an important contribution to the epidemiological
study of respiratory diseases, and a great opportunity to start addressing health inequalities
pertaining to respiratory health status that affect Aboriginal peoples and other vulnerable
groups in our society.
Conclusions
This study is one of the first to evaluate the epidemiology of COPD among Aboriginal peoples
of Canada over an extended period of time and using methods that allowed the identification
of Registered First Nations peoples, Métis and Inuit within the Aboriginal cohort. The study
demonstrated the existence of a large gap in the prevalence and incidence of COPD affecting
Aboriginal populations compared to their non-Aboriginal counterparts in an industrialized
country like Canada. Results of this research are important for the planning of respiratory
health services delivered to Aboriginal peoples in industrialized countries and to motivate fur-
ther evaluations of the determinants and pathways of COPD-related inequalities.
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